The expression levels of the CTA family members MAGE-3 and MAGE-4 mRNA are significantly higher in the peripheral blood of metastatic hepatocellular carcinoma patients than in a non-metastasis group, and they can be used to determine whether hepatoma cells undergo blood vessel metastasis 28. This evidence concerns the gene MAGEA3 and hepatocellular carcinoma.